← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
AntibodystaleAkesogovitecan), and chimeric an…Phase 2

Ivonescimab (Ivonescimab)

Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma · HER2

#HER2#Antibody#Phase2#인기#항체+5
임상시험 62상태 RECRUITING
ADCBiologicstaleMedical Enterprises Europe B.V.Phase 3

Mitomycin C (Mitomycin C)

Locally Advanced Cancer in the Anal Region · Urothelial Cancer

#UrothelialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 62상태 RECRUITING
ADCBiologicstaleNovartis PharmaceuticalsPhase 2

Mitoxantrone Hydrochloride (Mitoxantrone Hydrochloride)

Leukemia; Myelodysplastic Syndromes · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 30%임상시험 62상태 ACTIVE
ADCBiologicstaleThe Lymphoma Academic Research …vedotin plus doxorubicin [A…Phase 2

Oncovin (Oncovin)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 95%임상시험 62상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

Relatlimab (Relatlimab)

Various Advanced Cancer · FRα

#FR#Antibody#Phase2#인기#항체+5
효능 ORR 71.4%임상시험 62상태 RECRUITING
AntibodystaleJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
ADCBiologicstaleBristol-Myers SquibbPhase 1

Revlimid (Revlimid)

Lymphoma; Non-Hodgkin Lymphoma · Lymphoma

#Lymphoma#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 90%임상시험 62상태 RECRUITING
ADCBiologicstaleSuzhou Suncadia Biopharmaceutic…rezetecanPhase 3

SHR-A1811 (SHR-A1811)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
임상시험 62상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 2

sac-TMT (Sacituzumab Tirumotecan, Sacituzumab Tirumotecan (sac-TMT))

Gastroesophageal Junction; Gastroesophageal Adenocarcinoma · Gastroesophageal Junction

#GastroesophagealJunction#ADC#Phase2#인기#항체약물접합체+5
임상시험 62상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Standard Therapy (Standard Therapy)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 9%임상시험 62상태 RECRUITING
CGTBiologicstaleMerck Sharp & Dohme LLCPhase 2

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 90%임상시험 62상태 ACTIVE
CGTBiologicstaleZhongmou Therapeuticsvedotin in relapsed or refr…Phase 2

high dose (ZM-02, ZM-02 (high dose))

Retinitis Pigmentosa (RP) · Retinitis Pigmentosa (RP)

#RetinitisPigmentosaRP#CGT#Phase2#인기#세포유전치료+5
임상시험 62상태 RECRUITING
CGTBiologicstaleShanghai Unicar-Therapy Bio-med…Phase 1

chimeric antigen receptor T cell (chimeric antigen receptor T cell)

Pancreatic Cancer; CAR · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 62상태 ACTIVE
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
CGTBiologicstaleGenzyme, a Sanofi CompanyPhase 2

stem cells (stem cells)

Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+5
임상시험 62상태 DISCONTINUED
CGTBiologicstaleAbbottPhase 1

valproic acid (valproic acid)

Advanced Malignant Neoplasm; Castleman Disease · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
임상시험 62상태 DISCONTINUED
ADCBiologicstaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 77%임상시험 61상태 RECRUITING
CGTBiologicstaleAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#인기#세포유전치료+5
임상시험 61상태 DISCONTINUED
AntibodystaleRochegovitecan in patients with …Phase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase3#인기#항체+4
효능 ORR 75%임상시험 61상태 ACTIVE
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80.3%임상시험 61상태 ACTIVE

12 / 177 페이지

← 이전다음 →